---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-245724"
form_type: "8-K"
ticker: "WVE"
cik: "0001631574"
company_name: "Wave Life Sciences Ltd."
filed_at: "2023-09-28T23:59:59+00:00"
generated_at: "2026-06-10T07:38:54.493562+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Wave Life Sciences unveils INHBE siRNA for obesity, targets 5 new clinical candidates by 2025

## Summary
- New GalNAc-siRNA program targeting INHBE for metabolic disorders including obesity; expects clinical candidate in 4Q 2024.
- INHBE knockdown of 62% in DIO mice led to 16% lower body weight vs control at 5 weeks; visceral fat reduction in 8-week study.
- WVE-006 for AATD: dosing in healthy volunteers expected 4Q 2023; proof-of-mechanism data in AATD patients in 2024.
- Plans to select five new clinical candidates by year-end 2025, spanning RNA editing (correction and upregulation) and siRNA.
- WVE-N531 in DMD: muscle biopsy data show uptake in satellite cells after 3 doses; data from registrational Phase 2 (FORWARD-53) expected 2024.

## SEC filing metadata
- accession: 0001193125-23-245724
- form_type: 8-K
- ticker: WVE
- cik: 0001631574
- company_name: Wave Life Sciences Ltd.
- filed_at: 2023-09-28T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1631574/000119312523245724/0001193125-23-245724-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1631574/000119312523245724/d537767d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-245724
- JSON: https://secwatch.observer/filing/0001193125-23-245724.json
- Plain text: https://secwatch.observer/filing/0001193125-23-245724.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.